Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2300805 | 0.94 | KDM4E (0.34) | KDM4E | |
| SCHEMBL2299229 | 0.85 | KDM4E (0.31) | KDM4E | |
| SCHEMBL2297692 | 0.79 | TDP1 (0.41) | KDM4E | |
| SCHEMBL2295412 | 0.78 | PAOX (0.38) | KDM4E | |
| SCHEMBL2299127 | 0.76 | — | — | |
| SCHEMBL2296596 | 0.76 | SMN1; SMN2 (0.40) | KDM4E | |
| SCHEMBL2300241 | 0.73 | KDM4E (0.41) | KDM4E | |
| SCHEMBL2294529 | 0.72 | GLB1 (0.33) | — | |
| SCHEMBL2297096 | 0.71 | ATM (0.37) | — | |
| SCHEMBL2296528 | 0.71 | SIGMAR1 (0.33) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7999006-B2 | Anticancer agents; mitogen-activated protein kinases (MEK) | EXELIXIS, INC. (US) | 2011-08-16 | — | — | US | claimed |